Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Group 1 or the control group will receive a placebo sachet (containing maltodextrin manufactured by Jiujiang Hurirong, China) at a dose of 30 grams per day with food (twice a day) for
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 55 Years
Inclusion criteria
Inclusion criteria: Age range of 30-55 years 25=BMI<35 and no weight changes in the past 3 months having at least 6 months history of diabetes no insulin treatment and use of blood sugar lowering drugs no use of some drugs such as glucocorticoids, non-steroidal anti-inflammatory drugs not receiving omega-3 oils in the last 3 months not doing yoga exercises in the last 3 months not doing other physical activities during the study willingness to cooperate during the study
Exclusion criteria
Exclusion criteria: including skeletal-muscular injuries smoking alcohol hormone therapy long-term use of drugs use of nutritional supplements pregnancy breastfeeding history of taking a weight loss diet in the last 6 months or a special diet use of insulin suffering from thyroid disorders, Renal, hepatic,pulmonary anemia (Hb<13g/dl) cardiovascular diseases infectious diseases malignancies cognitive disorders during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HsCRP. Timepoint: The beginning of the study and 8 weeks later. Method of measurement: autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index (BMI). Timepoint: At baseline and two months after baseline. Method of measurement: Scale-Meter.;Energy intake, Daily macronutrient intake (carbohydrate, protein, fat). Timepoint: At baseline and two months after baseline. Method of measurement: 24-hour food recall questionnaire.;General Health. Timepoint: At baseline and two months after baseline. Method of measurement: ?Goldberg General Health Questionnaire_28 (GHQ28).;Blood pressure. Timepoint: At baseline and two months after baseline. Method of measurement: manometer.;Body fat percentage. Timepoint: At baseline and two months after baseline. Method of measurement: body composition.;Total antioxidant capacity. Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay kit.;Malondialdehyde. Timepoint: At baseline and two months after start of the study. Method of measurement: spectrofluorometer.;Fasting glucose. Timepoint: At baseline and two months after start of the study. Method of measurement: autoanalyzer.;Fasting insulin. Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay kit.;Fructosamine. Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay (ELISA) kit.;Pentosidine. Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay (ELISA) kit.;Total oxidant status (TOS). Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay kit.;Carboxymethyl lysine (CML). Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay (ELISA) kit.;Soluble receptor for advanced glycation end-products. Timepoint: At baseline and two months after start of the study. Method of measurement: enzyme-linked immunosorbent assay (ELISA) kit.;A | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParvin Dehghan
Tabriz University of Medical Sciences
Outcome results
None listed